Zheng Cai Selected Research

Latent Tuberculosis

1/2021

Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Cai Research Topics

Disease

14	Neoplasms (Cancer) 07/2022 - 01/2010
7	Glioma (Gliomas) 07/2022 - 01/2015
4	Thrombocytopenia (Thrombopenia) 01/2023 - 09/2015
2	Hemorrhage 01/2023 - 01/2021
2	Ischemic Stroke 01/2023 - 10/2019
2	Nervous System Diseases (Neurological Disorders) 01/2023 - 12/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2021
2	Fistula 11/2021 - 01/2021
2	COVID-19 01/2021 - 10/2020
2	Infections 10/2020 - 01/2019
2	Thrombosis (Thrombus) 10/2020 - 09/2015
2	Cerebral Infarction 10/2019 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 01/2019
2	Meningioma (Meningiomas) 08/2017 - 01/2017
1	Adenoma (Adenomas) 01/2023
1	Inflammation (Inflammations) 01/2022
1	Cysts 11/2021
1	Neurologic Manifestations (Neurological Manifestations) 11/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Heart Failure 01/2021
1	Pulmonary Embolism 01/2021
1	Diarrhea 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Latent Tuberculosis 01/2021
1	Ascites 01/2021
1	Arteriovenous Fistula 01/2021
1	Paralysis (Palsy) 01/2021
1	Liver Failure 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 03/2020
1	Acute Promyelocytic Leukemia 03/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Pancreatitis 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2010
4	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 09/2015
4	AntibodiesIBA 01/2023 - 09/2015
4	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2015
3	Platelet Factor 4IBA 01/2023 - 09/2015
3	AntigensIBA 01/2023 - 07/2016
3	Long Noncoding RNAIBA 08/2019 - 01/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 09/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2015
2	GlycosaminoglycansIBA 07/2016 - 09/2015
2	Phosphotransferases (Kinase)IBA 12/2012 - 12/2010
1	FructoseIBA 01/2023
1	Culture MediaIBA 01/2023
1	Sucrose (Saccharose)IBA 01/2023
1	Resistant StarchIBA 01/2023
1	MelatoninIBA 01/2023
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2023
1	PrebioticsIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	NAD (NADH)IBA 07/2022
1	Sirtuin 1IBA 07/2022
1	Nicotinamide N-MethyltransferaseIBA 07/2022
1	N-nitroso-N-methyltyramine (NNMT)IBA 07/2022
1	AlbuminsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Adenosine DeaminaseIBA 01/2022
1	Carvedilol (Coreg)FDA LinkGeneric 01/2021
1	GelatinIBA 01/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021
1	EmulsionsIBA 01/2021
1	Ethiodized Oil (Ethiodol)FDA Link 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	InterferonsIBA 01/2021
1	IodineIBA 01/2021
1	Iodized OilIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	heparin-binding hemagglutininIBA 01/2021
1	PowdersIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 10/2020
1	Blocking AntibodiesIBA 10/2020
1	CytokinesIBA 10/2020
1	O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA 08/2020
1	Arsenic Trioxide (Trisenox)FDA Link 03/2020
1	Liposomes (Liposome)IBA 01/2020
1	Amylases FDA Link 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	Volatile Fatty AcidsIBA 10/2019
1	LipidsIBA 10/2019
1	Butyric Acid (Butanoic Acid)IBA 10/2019
1	Competitive Endogenous RNAIBA 08/2019
1	graphene oxideIBA 07/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2019

Therapy/Procedure

11	Therapeutics 01/2023 - 12/2010
3	Drug Therapy (Chemotherapy) 01/2021 - 08/2018
2	Intranasal Administration 01/2021 - 12/2011
2	Lasers (Laser) 08/2020 - 07/2019
1	Operative Time 01/2023
1	Molecular Targeted Therapy 01/2023
1	Ligation 11/2021
1	Operative Surgical Procedures 11/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2020
1	Extracorporeal Membrane Oxygenation 10/2020
1	Transplantation 10/2019
1	Oral Administration 10/2019